Elevated serum interferon γ-inducible protein-10 in women with polycystic ovary syndrome
- 4 January 2017
- journal article
- pcos and-interferon-inducible-protein-10
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 33 (5) , 363-367
Abstract
Background: Interferon γ-induced protein 10 kDa (IP10/CXCL10) is a chemokine related to endocrine disorders; however, the serum concentrations of IP10 in women with polycystic ovary syndrome (PCOS) have not yet been reported. Therefore, we investigated whether IP10 is increased in PCOS patients and its potential clinical value in PCOS patients. Methods: For this research, the serum IP10, glucose, insulin, high sensitivity C-reactive protein (hs-CRP), follicle-stimulating hormone (FSH), luteinizing hormone (LH) and total testosterone (TT) concentrations were measured in 60 women with PCOS and healthy controls. Results: The median IP10 concentration was 45.60 pg/mL [interquartile range (IQR):29.75, 79.69], which was significantly higher than that of the body mass index (BMI)-matched controls (median: 36.46 pg/mL; IQR:28.98, 45.80). In the multivariate linear regression analysis, hs-CRP and the homeostasis model assessment of insulin resistance index (HOMA2-IR) were independent predictors of the IP10 values, while FSH was inversely associated with the IP10.No significant association was observed between the IP10 and BMI, glucose, LH and TT. Conclusions: The serum IP10 concentrations increase in women with PCOS, moreover, IP10 appears to be correlated with the inflammatory and IR statuses of PCOS. IP10 may be a potential biomarker to estimate the disease activity of PCOS.Keywords
This publication has 37 references indexed in Scilit:
- Poly Cystic Ovarian Syndrome: An Updated OverviewFrontiers in Physiology, 2016
- High-visfatin levels in women with polycystic ovary syndrome: evidence from a meta-analysisGynecological Endocrinology, 2015
- Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clampHuman Reproduction, 2013
- Editorial BoardStroke, 2013
- Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysisHuman Reproduction Update, 2009
- Obesity and extreme obesity, manifest by ages 20–24 years, continuing through 32–41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2005
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life SpanThe Journal of Clinical Endocrinology & Metabolism, 2005
- Endothelial Dysfunction in Young Women with Polycystic Ovary Syndrome: Relationship with Insulin Resistance and Low-Grade Chronic InflammationThe Journal of Clinical Endocrinology & Metabolism, 2004
- The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected PopulationThe Journal of Clinical Endocrinology & Metabolism, 2004
- IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo.Journal of Experimental Medicine, 1993